Jordi Guiu joins to IDIBELL as group leader and opens the Cell Plasticity and Regeneration group of the Regenerative Medicine Program
Six scientists from IDIBELL have received training to perform a scientific monologue in live and to produce an informative video on YouTube.
The group led by Dr. Óscar Martínez-Tirado will receive 180,000 euros in two years to develop a new therapy for Ewing’s sarcoma.
IDIBELL participates in the European Project Evomet, coordinated by IRB Barcelona, which will train future leaders in metastasis research
The goal is to train 15 young researchers in the understanding of metastatic processes and their evolution, with the aim to identify therapeutic solutions. The Evomet consortium is formed by 13 institutions, which include several of the best academic, clinical and industrial centres working in cancer research and metastasis research in Europe. Awarded in the …
Smoking in water pipes and passive exposure to the smoke they produce, increase the risk of lung cancer and other cardiovascular diseases. It is for this reason that its use should be regulated and compliance with the regulations guaranteed.
Dr. Carolina M. Florian project has been selected by La Caixa Health Research grants
ADmit Therapeutics receives 3.3 million euros from the European Commission to bring its early diagnosis test for Alzheimer’s to the market
The IDIBELL spin-off, created in 2017 and based in L’Hospitalet de Llobregat, is one of the 36 companies selected from among the 1,406 applications received in the EIC Accelerator call of the Horizon 2020 programme.
IDIBELL scientists fins a new combination of drugs to treat rhabdomyosarcoma, a highly aggressive tumor in children
The chemoresistance group of IDIBELL and ICO’s ProCURE Program, led by Alberto Villanueva, has transferred its experience in generating orthotopic mouse models in adult patients to the pediatric field.